Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
$18.58
$18.58
$16.07
$24.93
$9.29MN/A3,875 shs31,600 shs
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
$42.58
+0.1%
$4.11
$0.28
$17.38
$1.34B3.65373,201 shs667 shs
FXP
ProShares UltraShort FTSE China 50
$8.60
+1.1%
$9.68
$8.51
$31.44
$5.07M-0.7625,853 shs43,813 shs
Principal US Large-Cap Adaptive Multi-Factor ETF stock logo
PLRG
Principal US Large-Cap Adaptive Multi-Factor ETF
$25.70
$25.70
$0.00
$0.00
$6.42M0.97N/AN/A
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
0.00%0.00%0.00%0.00%0.00%
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
+0.10%+1.46%+2.21%+10.46%+1,314.46%
FXP
ProShares UltraShort FTSE China 50
0.00%-8.12%-10.51%-21.03%-72.82%
Principal US Large-Cap Adaptive Multi-Factor ETF stock logo
PLRG
Principal US Large-Cap Adaptive Multi-Factor ETF
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
$18.58
$18.58
$16.07
$24.93
$9.29MN/A3,875 shs31,600 shs
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
$42.58
+0.1%
$4.11
$0.28
$17.38
$1.34B3.65373,201 shs667 shs
FXP
ProShares UltraShort FTSE China 50
$8.60
+1.1%
$9.68
$8.51
$31.44
$5.07M-0.7625,853 shs43,813 shs
Principal US Large-Cap Adaptive Multi-Factor ETF stock logo
PLRG
Principal US Large-Cap Adaptive Multi-Factor ETF
$25.70
$25.70
$0.00
$0.00
$6.42M0.97N/AN/A
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
0.00%0.00%0.00%0.00%0.00%
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
+0.10%+1.46%+2.21%+10.46%+1,314.46%
FXP
ProShares UltraShort FTSE China 50
0.00%-8.12%-10.51%-21.03%-72.82%
Principal US Large-Cap Adaptive Multi-Factor ETF stock logo
PLRG
Principal US Large-Cap Adaptive Multi-Factor ETF
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
0.00
N/AN/AN/A
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
0.00
N/AN/AN/A
FXP
ProShares UltraShort FTSE China 50
0.00
N/AN/AN/A
Principal US Large-Cap Adaptive Multi-Factor ETF stock logo
PLRG
Principal US Large-Cap Adaptive Multi-Factor ETF
2.72
Moderate Buy$25.70N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
N/AN/AN/AN/AN/AN/A
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
N/AN/AN/AN/A$0.95 per shareN/A
FXP
ProShares UltraShort FTSE China 50
N/AN/AN/AN/AN/AN/A
Principal US Large-Cap Adaptive Multi-Factor ETF stock logo
PLRG
Principal US Large-Cap Adaptive Multi-Factor ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
N/AN/A0.00N/AN/AN/AN/AN/A
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
-$40.86MN/A0.00N/AN/A-81.29%-56.92%N/A
FXP
ProShares UltraShort FTSE China 50
N/AN/A0.00N/AN/AN/AN/AN/A
Principal US Large-Cap Adaptive Multi-Factor ETF stock logo
PLRG
Principal US Large-Cap Adaptive Multi-Factor ETF
N/AN/A15.72N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
$1.105.92%N/AN/AN/A
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
N/AN/AN/AN/AN/A
FXP
ProShares UltraShort FTSE China 50
$1.0412.09%N/AN/AN/A
Principal US Large-Cap Adaptive Multi-Factor ETF stock logo
PLRG
Principal US Large-Cap Adaptive Multi-Factor ETF
N/A1.41%N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
CEY
VictoryShares Emerging Market High Div Volatility Wtd ETF
N/A500,000N/ANot Optionable
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
N/A31.51 millionN/ANot Optionable
FXP
ProShares UltraShort FTSE China 50
N/A590,000N/ANot Optionable
Principal US Large-Cap Adaptive Multi-Factor ETF stock logo
PLRG
Principal US Large-Cap Adaptive Multi-Factor ETF
N/A250,000N/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com
Edge Therapeutics stock logo

Edge Therapeutics NASDAQ:EDGE

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.

ProShares UltraShort FTSE China 50 NYSEARCA:FXP

$8.60 +0.09 (+1.06%)
Closing price 09/12/2025 04:10 PM Eastern
Extended Trading
$8.60 0.00 (0.00%)
As of 09/12/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ProShares UltraShort FTSE China 50 (the Fund) seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the FTSE China 50 Index (the Index). The Index is comprised of 50 of the largest and most liquid Chinese stocks listed on the Hong Kong Stock Exchange (HKEX). The Fund's investment advisor is ProShare Advisors LLC.

Principal US Large-Cap Adaptive Multi-Factor ETF stock logo

Principal US Large-Cap Adaptive Multi-Factor ETF BATS:PLRG

$25.70 0.00 (0.00%)
As of 10/13/2023

The Principal US Large-Cap Adaptive Multi-Factor ETF (PLRG) is an exchange-traded fund that is based on the S&P 500 index. The fund is an actively-managed portfolio of US large-cap companies selected and weighted in consideration of several factors as well as the current market risk regime, as determined by the fund adviser. PLRG was launched on May 19, 2021 and is managed by Principal.